178 research outputs found
Early and Late Motherhood: Economic, Family Background and Social Conditions
The study investigates parental child rearing methods, structural factors relating to the family during adolescence geographic segregation, individual resource deficits and social background of first time late live births among 32 to 37 years old women and compare to teenagers before becoming teenage mothers. The purpose is to study if results will be consistent with the hypotheses that poverty, social deprivation during adolescence and low education are causes of teen childbearing but also childlessness among elder women in the age group 32 to 37 years old. Could childlessness as well as teenage motherhood bee seen as a consequence of social deprivation and lack of educational possibilities?A discrete-time proportional hazard Cox model is applied to analyze the longitudinal observations of population-based registers covering 1980-2003 for girls born in 1966. Results show a significant economic and social gradient for first-time teenage mothers. Teenagers who had experienced family separation or who were formerly in out-of-home care in particular had an increased risk of early childbearing. Results showed that teenage mothers were in every respect in a more disadvantaged position than pregnant teenagers who had an induced abortion.Quite the opposite pattern is disclosed for late motherhood. Late first time childbirth is more commonly seen among women with a better family background and educated position than childless women in the same age group. The late first-time pregnant women who chose abortion are in a more disadvantaged position than the women who become a mother for the first time in the age group 32 to 37 years old.Conclusion: Disadvantage during adolescence is a precursor for teenage child bearing while parental unemployment and poverty are precursors of lifetime childlessness. While social disadvantage is a precursor for first time late abortion among 32 to 37 years old women, the teenage mothers are in a more disadvantage position than teenagers who choose induced abortions. Social disadvantages inflict at the same time early motherhood and childlessness because social disadvantages influence young women differently than elder women
Seroprevalence of Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum in Danish horses
<p>Abstract</p> <p>Background</p> <p><it>Borrelia burgdorferi </it>sensu lato and <it>Anaplasma phagocytophilum </it>are able to infect horses. However, the extend to which Danish horses are infected and seroconvert due to these two bacteria is unknown. The aim of the present study was to evaluate the seroprevalence of <it>B. burgdorferi </it>sensu lato and <it>A. phagocytophilum </it>in Danish horses.</p> <p>Methods</p> <p>A total of 390 blood samples collected from all major regions of Denmark and with a geographical distribution corresponding to the density of the Danish horse population were analyzed. All samples were examined for the presence of antibodies against <it>B. burgdorferi </it>sensu lato and <it>A. phagocytophilum </it>by the use of the SNAP<sup>®</sup>4DX <sup>® </sup>ELISA test.</p> <p>Results</p> <p>Overall, 29.0% of the horses were seropositive for <it>B. burgdorferi </it>sensu lato whereas 22.3% were seropositive for <it>A. phagocytophilum</it>.</p> <p>Conclusions</p> <p>Antibodies against <it>B burgdorferi </it>sensu lato and <it>A. phagocytophilum </it>are commonly found among Danish horses thus showing that Danish horses are frequently infected by these organisms.</p
A Diagnostic Survey of Aborted Equine Fetuses and Stillborn Premature Foals in Denmark
Background: Loss of pregnancy in mares can have many different causes, including both infectious and non-infectious conditions. Extrapolation of findings from other studies is often uncertain as the significance of each cause varies across regions. Causes of pregnancy loss in mares have never been thoroughly studied in Denmark, so a prospective cross-sectional cohort study targeting the entire Danish population of pregnant mares was performed over a period of 13 months to obtain knowledge of the significance of individual causes. Fifty aborted or prematurely delivered stillborn fetuses were submitted for necropsy and examined by a panel of diagnostic laboratory methods.Results: Overall, a cause of fetal loss was established for 72% of the examined cases. Most cases (62%) were lost due to a non-infectious cause, of which obstruction of the feto-placental blood circulation due to severe torsion of the umbilical cord was most prevalent. Pregnancy loss due to a variety of opportunistic bacteria, including bacteria not previously associated with abortion in mares, accounted for 12%, while equid alphaherpesvirus (EHV) type 1 was the cause of pregnancy loss in 8% of the cases. EHV type 4 and Chlamydiaceae species were identified in some cases, but not regarded as the cause of fetal loss.Conclusion: Umbilical cord torsion was found to be the most prevalent cause of fetal loss in Danish mares, while infectious causes such as EHV type 1 and streptococci only accounted for a minor proportion of the losses. The study highlights the need for defined criteria for establishing an abortion diagnosis in mares, particularly in relation to EHV types 1 and 4
Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study
Objective To test the hypothesis that xanthelasmata and arcus corneae, individually and combined, predict risk of ischaemic vascular disease and death in the general population
Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study
Chronic migraine; Episodic migraine; EptinezumabMigraña crónica; Migraña episódica; EptinezumabMigranya crònica; Migranya episòdica; EptinezumabBackground
Migraine is a disabling neurological disease adversely affecting many aspects of life. Most patients are still required to have failed several older oral preventive therapies before being reimbursed for a preventive, migraine-specific anti-calcitonin gene-related peptide treatment. In the 24-week placebo-controlled portion of DELIVER, eptinezumab was shown to reduce migraine frequency and resulted in higher migraine responder rates compared with placebo in patients with two to four previous preventive treatment failures. This subgroup analysis assessed if demographic or clinical characteristics were associated with differences in preventive benefits.
Methods
Migraine frequency reductions and responder rates (i.e., the proportion of patients reaching a ≥50% and ≥75% reduction in monthly migraine days relative to baseline) were determined in the total population and predefined subgroups by sex, age, migraine frequency (chronic migraine, episodic migraine, high-frequency episodic migraine, low-frequency episodic migraine), medication overuse, medication-overuse headache, and previous preventive treatment failures (2, >2). The primary endpoint was change from baseline in monthly migraine days over weeks 1–12.
Results
Eptinezumab 100 and 300 mg reduced monthly migraine days more than placebo over weeks 1–12 (−4.8 and −5.3 vs –2.1, respectively; p < 0.0001). In most subgroups, eptinezumab-treated patients demonstrated larger monthly migraine days reductions from baseline over weeks 1–12 than patients receiving placebo, with reductions maintained or increased over weeks 13–24. For ≥50% and ≥75% migraine responder rates, the odds ratios versus placebo all numerically favored eptinezumab.
Conclusion
Eptinezumab had larger monthly migraine days reductions and higher responder rates than placebo across clinically relevant subgroups showing that, across different demographic populations and clinical characteristics, eptinezumab is effective in patients with migraine and prior preventive treatment failures.
Trial Registration: ClinicalTrials.gov (Identifier: NCT04418765)The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was sponsored and funded by H. Lundbeck A/S, including medical writing support for the development of the manuscript. In collaboration with the academic authors, the sponsor participated in the design and conduct of the study and in the collection, management, analysis, and interpretation of the data. The preparation, review, and approval of the manuscript was undertaken by all authors and by a professional medical writer and editor funded by the sponsor. All authors and H. Lundbeck A/S prepared, reviewed, and approved the final version of the manuscript and made the decision to submit the manuscript for publication. The sponsor did not have the right to veto publication or to control the decision regarding to which journal the manuscript was submitted
- …